covid
Allergologia et Immunopathologia Omalizumab. An option in vernal keratoconjunctivitis?
Journal Information

Statistics

Follow this link to access the full text of the article

Research letter
Omalizumab. An option in vernal keratoconjunctivitis?
J. Sáncheza,b,
Corresponding author
jotamsc@yahoo.com

Corresponding author.
, R. Cardonaa,c
a Group of Clinical and Experimental Allergy (GACE), University of Antioquia, Medellín, Colombia
b Foundation for the Development of Medical and Biological Sciences (FUNDEMEB), Cartagena, Colombia
c Clinical Allergy, University of Antioquia, Medellín, Colombia
Read
6269
Times
was read the article
1940
Total PDF
4329
Total HTML
Share statistics
Article information
ISSN: 03010546
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 20 13 33
2025 11 83 87 170
2025 10 51 35 86
2025 9 45 75 120
2025 8 522 37 559
2025 7 54 19 73
2025 6 43 4 47
2025 5 64 4 68
2025 4 51 4 55
2025 3 59 9 68
2025 2 46 5 51
2025 1 42 4 46
2024 12 29 3 32
2024 11 32 6 38
2024 10 17 4 21
2024 9 55 9 64
2024 8 32 7 39
2024 7 37 7 44
2024 6 42 2 44
2024 5 14 16 30
2024 4 21 35 56
2024 3 31 17 48
2024 2 42 10 52
2024 1 49 10 59
2023 12 32 4 36
2023 11 41 9 50
2023 10 61 8 69
2023 9 59 11 70
2023 8 37 9 46
2023 7 37 9 46
2023 6 33 3 36
2023 5 52 9 61
2023 4 65 6 71
2023 3 68 5 73
2023 2 26 13 39
2023 1 31 6 37
2022 12 29 8 37
2022 11 36 20 56
2022 10 16 9 25
2022 9 30 13 43
2022 8 30 16 46
2022 7 26 12 38
2022 6 21 5 26
2022 5 35 11 46
2022 4 18 9 27
2022 3 33 7 40
2022 2 16 13 29
2022 1 29 13 42
2021 12 14 15 29
2021 11 22 16 38
2021 10 29 14 43
2021 9 17 20 37
2021 8 12 12 24
2021 7 20 15 35
2021 6 11 11 22
2021 5 23 12 35
2021 4 33 10 43
2021 3 17 25 42
2021 2 41 22 63
2021 1 11 32 43
2020 12 2 14 16
2020 11 0 9 9
2020 10 0 8 8
2020 9 0 2 2
2020 8 0 5 5
2020 7 0 4 4
2020 6 0 3 3
2020 5 0 20 20
2020 4 0 17 17
2020 3 0 13 13
2020 2 0 13 13
2020 1 0 17 17
2019 12 0 7 7
2019 11 0 6 6
2019 10 0 4 4
2019 9 0 7 7
2019 8 0 7 7
2019 7 0 11 11
2019 6 0 18 18
2019 5 0 59 59
2019 4 0 13 13
2019 3 0 7 7
2019 2 0 2 2
2019 1 0 6 6
2018 12 0 2 2
2018 5 0 2 2
2018 3 1 2 3
2018 2 3 6 9
2018 1 13 15 28
2017 12 10 4 14
2017 11 10 9 19
2017 10 11 21 32
2017 9 11 11 22
2017 8 16 14 30
2017 7 17 8 25
2017 6 18 22 40
2017 5 23 18 41
2017 4 18 18 36
2017 3 17 34 51
2017 2 26 16 42
2017 1 26 7 33
2016 12 22 20 42
2016 11 31 18 49
2016 10 38 32 70
2016 9 40 16 56
2016 8 16 5 21
2016 7 14 1 15
2016 6 24 40 64
2016 5 14 34 48
2016 4 22 24 46
2016 3 16 32 48
2016 2 19 22 41
2016 1 29 24 53
2015 12 25 18 43
2015 11 13 19 32
2015 10 20 25 45
2015 9 20 12 32
2015 8 39 7 46
2015 7 30 11 41
2015 6 14 5 19
2015 5 12 6 18
2015 4 16 3 19
2015 3 12 9 21
2015 2 6 6 12
2015 1 12 3 15
2014 12 31 12 43
2014 11 13 1 14
2014 10 15 7 22
2014 9 31 6 37
2014 8 15 5 20
2014 7 12 8 20
2014 6 20 3 23
2014 5 5 4 9
2014 4 11 2 13
2014 3 43 17 60
2014 2 47 16 63
2014 1 43 9 52
2013 12 43 9 52
2013 11 51 11 62
2013 10 49 13 62
2013 9 51 8 59
2013 8 28 5 33
2013 7 40 9 49
2013 6 28 3 31
2013 5 41 10 51
2013 4 34 13 47
2013 3 37 7 44
2013 2 18 11 29
2013 1 12 6 18
2012 12 5 4 9
2012 11 4 6 10
2012 10 5 7 12
2012 9 1 1 2
2012 8 278 0 278
Show all

Follow this link to access the full text of the article